This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Explorna Therapeutics Sp. Z O.O., Uniwersytet Warszawski. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Pawel Sikorski: Innovator in mRNA Technology
Introduction
Pawel Sikorski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of mRNA technology, particularly through his innovative patent related to mRNA 5'-end cap analogs. His work has implications for various applications in biotechnology and medicine.
Latest Patents
Pawel Sikorski holds a patent titled "mRNA 5'-end cap analogs, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule or peptide." This invention pertains to new mRNA 5' end cap analogs, RNA molecules containing them, their uses, and methods for their in vitro synthesis. Additionally, it includes a method for protein or peptide synthesis in vitro or in cell cultures, which encompasses the translation of the RNA molecule. He has 1 patent to his name.
Career Highlights
Throughout his career, Pawel has worked with prominent institutions, including the University of Warsaw and Explorna Therapeutics Sp. z o.o. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Pawel has collaborated with several professionals in his field, including Marcin Warminski and Joanna Kowalska. These partnerships have enriched his work and fostered innovation in mRNA research.
Conclusion
Pawel Sikorski is a distinguished inventor whose work in mRNA technology is paving the way for future advancements in biotechnology. His contributions are vital to the ongoing development of RNA-based therapies and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile